CLINICAL_TRIALS
trial_result
· 2020-09-03
Clinical Trial Update: Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery [Phase 3]
Summary
Phase 3 trial update for mapracorat ophthalmic suspension to treat ocular inflammation after cataract surgery has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bausch & Lomb Incorporated | Conditions: Cataract | Phase 3 | Status: COMPLETED | Results posted: 2020-09-03